NEK9 and central nervous system cancer: There were more than 8% of cases with a higher protein level of 12 SKGs (CDCP1, CDKL5, CSNK1E, IGF2R, IQCD, MAP4K3, MELK, NEK9, STK3, TBRG4, ULK4, and VRK1) in glioma (Figure 2C, grey bars).